AstraZeneca, the United Kingdom’s pharmaceutical giant, has entered a strategic partnership with Eccogene, a Shanghai-based biotech firm, to co-develop a groundbreaking pill designed to combat obesity and type 2 diabetes.
This alliance marks AstraZeneca’s significant foray into the burgeoning sector of weight management medications, underpinned by an exclusive licensing contract...Read More
The link between maternal obesity and the long-term risk of cardiovascular disease has been further solidified by new research findings. A study led by Northwestern University in the United States has shone a light on the significant health risks faced by women who enter pregnancy with obesity.
The research team discovered that women with obesity before conception are more susceptible to...Read More
Researchers in a pivotal study recently featured in Nature Communications have uncovered vital insights into why individuals with obesity are at an elevated risk for severe influenza. This comprehensive investigation combines both human clinical data and animal model analysis to unravel the complexities of immune response in obesity that heighten the vulnerability to influenza.
The global...Read More
In the competitive landscape of obesity pharmacotherapy, Pfizer is on the cusp of revealing pivotal trial data for its investigational drug danuglipron. This oral medication, administered twice daily, is poised to challenge the market dominance of prominent weight-loss therapies Wegovy and Mounjaro.
Danuglipron operates by influencing the glucagon-like peptide-1 (GLP-1) receptor, which has...Read More
John Feenie, CEO, and Dzidek Sabat, Product Development Manager, attended the Independent Ageing Conference in Aichi, Japan, in mid-October. The Expo attracted over 950 delegates worldwide, drawn to Aichi by Japan’s leadership in various aspects of dementia care, both clinical and societal.
CCH, initially focused on courses in obesity care and, more recently, digital health, has...Read More
Dr. Richard Tytus, a seasoned medical professional from Hamilton, Ontario, has long championed the merits of virtual healthcare. Being at the helm of a family health team, which comprises around 30 healthcare experts and related professionals, he’s been an early adopter of telemedicine, even before it became a mainstream approach during the COVID-19 pandemic.
Discovering the...Read More
Recent research indicates that the combination of automated insulin delivery and continuous glucose monitoring could be an effective method for regulating blood sugar levels in hospitalised adults suffering from diabetes.
A collaborative study from Emory University, Stanford University, and the University of Virginia recently published in Diabetes Technology & Therapeutics, involved...Read More